SARS-CoV-2 3CLpro-IN-6
Modify Date: 2024-01-02 18:14:42
SARS-CoV-2 3CLpro-IN-6 structure
|
Common Name | SARS-CoV-2 3CLpro-IN-6 | ||
|---|---|---|---|---|
| CAS Number | 302821-53-0 | Molecular Weight | 405.36 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C22H15NO7 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of SARS-CoV-2 3CLpro-IN-6SARS-CoV-2 3CLpro-IN-6 is a reversible covalent inhibitor of SARS-CoV-2 3CL protease. SARS-CoV-2 3CLpro-IN-6 has potent inhibitory activity for SARS-CoV-2 3CLpro with an IC50 value of 4.9 μM. SARS-CoV-2 3CLpro-IN-6 can be used for the research of coronavirus disease 2019 (COVID-19)[1]. |
| Name | SARS-CoV-2 3CLpro-IN-6 |
|---|
| Description | SARS-CoV-2 3CLpro-IN-6 is a reversible covalent inhibitor of SARS-CoV-2 3CL protease. SARS-CoV-2 3CLpro-IN-6 has potent inhibitory activity for SARS-CoV-2 3CLpro with an IC50 value of 4.9 μM. SARS-CoV-2 3CLpro-IN-6 can be used for the research of coronavirus disease 2019 (COVID-19)[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 4.9 μM (SARS-CoV-2 3CLpro)[1] |
| In Vitro | SARS-CoV-2 3CLpro-IN-6 (Compound 13) (0-100 μM) has potent inhibitory activity for SARS-CoV-2 3CLpro with IC50 value of 4.9 μM[1]. SARS-CoV-2 3CLpro-IN-6 (5, 10 μM) has typical covalent inhibition behavior with time-dependent activity[1]. |
| References |
| Molecular Formula | C22H15NO7 |
|---|---|
| Molecular Weight | 405.36 |